Literature DB >> 27452464

Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures.

Yuki Sugaya1, Maya Yamazaki2, Motokazu Uchigashima3, Kenta Kobayashi4, Masahiko Watanabe3, Kenji Sakimura2, Masanobu Kano5.   

Abstract

Endocannabinoid signaling is considered to suppress excessive excitability of neural circuits and to protect the brain from seizures. However, the precise mechanisms of this effect are poorly understood. Here, we report that 2-arachidonoylglycerol (2-AG), one of the two major endocannabinoids, is crucial for suppressing seizures. We found that kainate-induced seizures in mice lacking the 2-AG synthesizing enzyme, diacylglycerol lipase α, were much more severe compared with those in cannabinoid CB1 receptor knockout mice and were comparable to those in mice lacking both CB1- and CB2-receptor-mediated signaling. In the dentate gyrus, 2-AG suppressed excitatory input around the inner and middle molecular layers through CB1 and presumably CB2 receptors, respectively. This 2-AG-mediated suppression contributed to decreased granule cell excitability and the dampening of seizures. Furthermore, lack of 2-AG signaling enhanced kindling epileptogenesis and spontaneous seizures after kainate-induced status epilepticus. These results highlight critical roles of 2-AG signaling in the suppression of epileptic seizures.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27452464     DOI: 10.1016/j.celrep.2016.06.083

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  31 in total

Review 1.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

Review 2.  Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Authors:  Evan C Rosenberg; Pabitra H Patra; Benjamin J Whalley
Journal:  Epilepsy Behav       Date:  2017-02-09       Impact factor: 2.937

Review 3.  Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder.

Authors:  Mariah M Wu; Xinwen Zhang; Melissa J Asher; Stanley A Thayer
Journal:  Brain Res       Date:  2019-09-17       Impact factor: 3.252

Review 4.  G protein-coupled receptors in acquired epilepsy: Druggability and translatability.

Authors:  Ying Yu; Davis T Nguyen; Jianxiong Jiang
Journal:  Prog Neurobiol       Date:  2019-08-24       Impact factor: 11.685

5.  Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.

Authors:  Parisa Zareie; Mehdi Sadegh; Mohammad Reza Palizvan; Homeira Moradi-Chameh
Journal:  Metab Brain Dis       Date:  2018-03-04       Impact factor: 3.584

6.  Dentate gyrus mossy cells control spontaneous convulsive seizures and spatial memory.

Authors:  Anh D Bui; Theresa M Nguyen; Charles Limouse; Hannah K Kim; Gergely G Szabo; Sylwia Felong; Mattia Maroso; Ivan Soltesz
Journal:  Science       Date:  2018-02-16       Impact factor: 47.728

7.  The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.

Authors:  Qing Xin; Fei Xu; Devin H Taylor; Jing-Fu Zhao; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2020-10-06       Impact factor: 6.150

8.  Maintenance of the Innate Seizure Threshold by Cyclooxygenase-2 is Not Influenced by the Translational Silencer, T-cell Intracellular Antigen-1.

Authors:  Yifan Gong; James A Hewett
Journal:  Neuroscience       Date:  2018-01-11       Impact factor: 3.590

9.  Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.

Authors:  Shane Rowley; Xiaofei Sun; Isabel V Lima; Alexandra Tavenier; Antonio Carlos Pinheiro de Oliveira; Sudhansu K Dey; Steve C Danzer
Journal:  Epilepsia       Date:  2017-11-03       Impact factor: 5.864

10.  Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model.

Authors:  Jenny L Wilkerson; Giulia Donvito; Travis W Grim; Rehab A Abdullah; Daisuke Ogasawara; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2017-10-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.